Drug Type Small molecule drug |
Synonyms 1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one, 2,3-Dimethyl-1-phenyl-5-pyrazolone, Analgesine + [5] |
Target |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC11H12N2O |
InChIKeyVEQOALNAAJBPNY-UHFFFAOYSA-N |
CAS Registry60-80-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01776 | Antipyrine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Otitis Media | - | - | - |
Pain | - | - | - |
Phase 2 | 112 | (Antipyrine and Benzocaine Otic Solution) | knsqggcopb(xhebuqivnp) = rcihqqmzdk ieujjgxdyn (zgwjbyntii, beziwnnhzq - drmirabrgo) View more | - | 31 Aug 2018 | ||
Placebo Otic solution+Antipyrine Otic Solution (Antipyrine Otic Solution) | knsqggcopb(xhebuqivnp) = vsvoekhppp ieujjgxdyn (zgwjbyntii, jfvvsjmrmo - psvkknocle) View more |